Type:
Educational Exhibit
Keywords:
Not applicable, Cancer, Staging, MR, Pelvis, Oncology, Genital / Reproductive system female, Genitourinary
Authors:
V. M. Vilela1, M. V. A. Soares1, A. M. PEREIRA2, L. D. D. Souza1, A. S. D. A. Bezerra3, W. De Paula3, M. Crosara1, K. Machado1, G. Cintra1; 1Brasília/BR, 2BRASÍLIA, DISTRITO FEDERAL/BR, 3Brasília, DF/BR
DOI:
10.26044/ecr2020/C-04331
Background
Cervical cancer is one of the most prevalent cancers among females.
Global Cancer Observatory (2018) ranks cervical cancer as the fourth most common cancer in women worldwide and as the second most common cancer in low and middle-income countries. Invasive uterine cervical cancer is a disease that primarily afflicts women who lack access to preventive health care, such as Papanicolaou test screening and HPV vaccine.
Brazil has a complex scenario when it comes to cervical cancer statistics. Global prevalence ranks as the third most frequent cancer in the female population. Still, there is significant variability in disease distribution due to socioeconomic factors, ranging from 2.88/100,000 in wealthier states to 18.83/100,000 in poorer states[1].
The current FIGO staging system for cervical cancer, updated in 2018, highlights and endorses the critical role of imaging for proper preoperative assessment[2,3](Fig. 1,Fig. 2).